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CD4+ T cells provide the major target for HIV infection initiation but productive viral infection is 
accompanied with CD4 receptor down-modulation. However, it is still not completely understood 
which cell subsets support HIV infection and replication in vivo and contribute to plasma viremia. 
Under the assumption that cell-associated HIV nucleotide sequences, quasi-identical to plasma-
derived sequences, originate from HIV infected cells producing plasma virus, we analyzed plasma 
and cell-associated HIV sequences in sorted memory CD45RA- T cell populations including CD4low/-
/CD8- T cells, regulatory T cells (Tregs, CD4+CD25+FoxP3+), T-follicular helper cells (Tfh, 
CD4+CXCR5+) and non-T-follicular helper cells (non-Tfh, CD4+CXCR5-). A nested PCR was used 
to amplify, clone and sequence the highly variable HIV Envelope (Env) V1V3 region (HxB6559 to 
7320) from the sorted cell populations. Nucleotide sequences were aligned with respect to the 
predicted amino acid sequence of the reference alignment using MEGA6. Up to 4 substitutions 
between cell and plasma-associated sequences were counted as quasi-identical. Collectively, 621 
EnvV1V3 sequences from 9 viremic HIV positive subjects were analyzed. Dual infection evidence 
was detected in 4 subjects and quasi-identical cell-plasma sequence pairs were detected in 5 of the 9 
subjects. For patient H76 3 cell-derived sequences from the CD4low/-/CD8- T cell subset were quasi-
identical with 4 distinct plasma sequences. For patient H241 17 cell-derived sequences from the 
CD4+CD25+FoxP3+ T cell subset were quasi-identical with 2 plasma sequences. For patient H304 1 
CD4+CXCR5+ and 1 CD4+CXCR5- cell subset was quasi-identical with 1 plasma sequence. For 
patient H442 1 CD4+CXCR5- cell subset was quasi-identical with 10 plasma-derived sequences and 
1 CD4low/-/CD8- T cell subset was quasi-identical with 1 plasma-derived sequence. For H446 1 
CD4+CXCR5- T cell subset was quasi-identical with 1 plasma derived sequence and further 2 
CD4+CXCR5- T cell subsets were quasi-identical with 1 other plasma derived sequence. These results 
are consistent with the concept that the majority of infected memory CD4 T cells in peripheral blood 
may not contribute to plasma viremia. Furthermore, none of the cell subset-derived sequences 
preferentially clustered with plasma virus sequences. Rather, the data indicate that all of the studied 













Während CD4+ T-Zellen das Hauptziel einer beginnenden HIV-Infektion darstellen, geht eine 
produktive Virusinfektion mit einer Herabregulation der CD4-Rezeptoren einher. Bis heute ist jedoch 
nicht eindeutig geklärt, welche Zellpopulationen eine HIV-Infektion und Replikation in vivo fördern, 
und zur Plasmavirämie beitragen. Um dies genauer zu charakterisieren, haben wir Plasma und Zell 
assoziierte HIV Sequenzen aus separierten CD45RA- T-Gedächtniszellpopulationen, einschließlich 
CD4niedrig/-/CD8- T-Zellen, regulatorischen T-Zellen (Tregs, CD4+CD25+FoxP3+), follikulären T-
Helferzellen (Tfh, CD4+CXCR5+) und nicht-follikulären T-Helferzellen (nicht-Tfh, CD4+CXCR5-) 
untersucht. Hierbei nahmen wir an, dass Zell assoziierte HIV-Nukleotidsequenzen, quasi-identisch 
zu Plasma assoziierten Sequenzen, ihren Ursprung aus HIV-infizierten, Virus produzierenden Zellen 
haben.  Um die hochvariable HIV Envelope (Env) V1V3 Region (HxB6559 bis 7320) aus geordneten 
Zellpopulationen zu amplifizieren, klonieren und zu sequenzieren, wurde eine nested-PCR 
verwendet. Die resultierenden Nukleotidsequenzen wurden in Aminosäuresequenzen übersetzt, und 
mithilfe von MEGA6 auf die Referenzsequenz ausgerichtet. Bis zu 4 Substitutionen zwischen Zell- 
und Plasma assoziierten Sequenzen wurden als quasi-identisch gewertet. Insgesamt wurden 621 
EnvV1V3-Sequenzen von 9 viremischen, HIV-positiven Probanden analysiert. Dabei wurden bei 4 
Probanden Doppelinfektionen mit unterschiedlichen HIV-Stämmen nachgewiesen und quasi-
identische Zell-Plasma-Sequenzpaare bei 5 der 9 Probanden entdeckt. Im Detail waren bei Patient 
H76 3 Sequenzen der CD4niedrig/-/CD8- T-Zellpopulation quasi-identisch zu 4 Plasmasequenzen. Für 
Patient H241 waren 17 Sequenzen der CD4+CD25+FoxP3+ T-Zellen quasi-identisch zu 2 
Plasmasequenzen. Für Patient H304 war 1 Sequenz der CD4+CXCR5+ T-Zell Population und 1 
Sequenz der CD4+CXCR5- T-Zellpopulation quasi-identisch zu 1 Plasma assoziierten Sequenz. Bei 
Patient H442 wurde 1 Sequenz der CD4+CXCR5- Zell assoziierten Population quasi-identisch mit 10 
Plasma assoziierten Sequenzen, sowie 1 CD4niedrig/-/CD8- T-Zell Population quasi identisch mit 1 
Plasma assoziierten Sequenz gefunden. In Patient H446 wurde 1 CD4+CXCR5- T-Zellpopulation 
quasi-identisch mit 1 Plasma assoziierten Population und 2 weitere CD4+CXCR5- T-Zellpopulationen 
quasi-identisch mit einer anderen Plasma assoziierten Population entdeckt. Alles in allem wurde keine 
einzelne Zellpopulation identifiziert, die dominant Plasma assoziierte Sequenzen produziert. Diese 
Ergebnisse unterstützen vielmehr das Konzept, dass alle der untersuchten CD4 T-Gedächtniszellen 
im peripheren Blut zur Plasmavirusproduktion beitragen und/oder kürzlich infiziert wurden.
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Human immune deficiency virus (HIV) infection induces an ongoing CD4+ T cell depletion and 
results in a severe immune system vulnerability towards opportunistic infections, which leads in 
progress to the fulminant Acquired Immune Deficiency Syndrome (AIDS). 
A large meta-analysis (Patel et al., 2014) revealed accurate estimates of per-act HIV transmission 
risks from various exposures. Parental exposure routes through blood transfusions revealed the 
highest risk for HIV transmission with 92.5% (9250 transmissions per 10000 exposures to an infected 
source). Needle sharing of drug users revealed 0.63% (63 transmissions per 10000 exposures to an 
infected source) and percutaneous needle stick with 0.23% (23 transmissions per 10000 exposures to 
an infected source). For pathways through semen or mucosal surfaces highest transmission rates for 
individuals with no condom or antiretroviral therapy use was detected for receptive anal intercourse 
with 1.38% (138 transmissions per 10000 exposures), followed by 0.11% (11 transmissions per 10000 
exposures) for insertive anal intercourse, 0.08% (8 transmissions per 10000 exposures) for receptive 
penile-vaginal intercourse and 0.04% (4 transmissions per 10000 exposures) for insertive penile-
vaginal intercourse. For receptive and insertive oral sex the transmission risk was suggested to be low 
but not zero, as the estimation is often confounded by complex patterns of sexual exposure such as 
higher-risk exposures that are accompanied with the same sexual encounter. Among 8965 receptive 
oral sex acts no transmission could be observed. Although HIV transmission via oral sex would be 
plausible no precise numeric estimate could be provided. Vertical transmission from mother to child 
revealed a 22.6% risk (2260 transmissions per 10000 exposures to an infected source). 
 
The viral crossing of the mucosa is enabled via cell free virions, infected cells, or virion associated 
with Langerhans cells, dendritic cells (DCs) or monocytes/macrophages and effects primarily CD4+ 
T cells. The virus can also infect natural killer (NK) cells, mucosal and cervical epithelial cells, 
mastocytes, astrocytes and microglia in the central nervous system, skin fibroblasts and bone marrow 
stem cells (Dahabieh, Battivelli and Verdin, 2015).  
 
Mechanisms of early events of HIV transmission remain not completely understood as infected 
individuals are difficult to identify, caused by the frequent absence of clinical symptoms during the 
beginning of infection. Based on studies of the non-human primate simian immunodeficiency virus 
(SIV) infection model, lymph nodes (LN) and the gut-associated lymphoid tissue (GALT) play an 
important role. Particularly in the GALT, within the intestinal lamina propria in transition to an acute 
status of infection, the virus leads to rapid depletion of CD4+ memory T cells, the major target for 
HIV replication, (Moir, Chun and Fauci, 2011).  
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An earlier study of Mattapallil et al. (2005) revealed that the efficient infected memory CD4+ T cell 
depletion, in mucosal tissue as well as LN and peripheral blood peaks in means at 10-14 days after 
infection while at least some viral gene expression takes place. The distinct depletion comprises about 
80% of the infected cells by various mechanisms. These mechanisms include CD8-T cell killing, that 
detect infected or virus triggered cytopathic mechanisms and virus-induced cytolysis associated with 
cellular activation.  
In the chronic stage, generally characterized by slow naive and memory CD4+ T cell loss, only low 
frequencies of HIV infected CD4+ T cells, despite high plasma viremia could be detected in earlier 
studies. Naive CD4+ T cells were found to be nearly resistant to infection (Nishimura et al., 2004). 
Hence, the severe memory CD4 T cell depletion is partially masked by this unaffected naive T cell 
population to infection (Mattapallil et al., 2005). 
 
While peripheral blood contains only 2-5% of all lymphocytes, the gastrointestinal mucosa presents 
the largest lymphoid organ of the body and is known to be highly permissive for HIV-1 entry, the 
dominant site for HIV-1 replication and hosts large amounts of proinflammatory, HIV-1 stimulating 
cytokines (Cerf-Bensussan and Guy-Grand, 1991; Smit-McBride et al., 1998; McGowan et al., 2004). 
Evidence of CD4+ T cell depletion could be detected in both but significantly larger in mucosa 
mononuclear cells and less in PBMCs during acute and early HIV-1 infection. Further the mucosal 
CD4+ T cell depletion occurs before changes in PBMCs appear. Based on investigations in both SIV 
infection and acute or early HIV-1 infected individuals CD4+ T cell depletion primarily takes place 
in the effector sites, potentially through decreased cell proliferation, apoptosis or activation-induced 
cell death (Krammer, 2000). These mechanisms lead to degraded homing of cells to the effector sites 
from peripheral compartments after antigen detection through direct cytopathic effects by the HIV-1 
virus, immune activation-induced cell death or both (McCune, 2001). Expression of HIV-1 RNA was 
detected predominantly in the lymphoid follicles or T cell zone and germinal center of the 
gastrointestinal mucosa inductive site, possible through the effector compartment loss at the time of 
biopsy sampling (Mehandru et al., 2004). 
 
High replication of HIV in memory CD4+ T cells is likely to contribute to high plasma viremia. 
Plasma peak viremia appears 2 to 3 weeks after exposure if the patient is not undergoing Antiretroviral 
Therapy (ART), then decreases rapidly and subsequently reaches a steady state or certain set point 
that indicates the progression of infection (Moir, Chun and Fauci, 2011). Besides the GALT the virus 
spreads also systemically in all lymphatic tissue (LT) and establishes stable viral reservoirs in latently 
infected resting and proliferating CD4+ T cells, which present challenges in virus elimination. Likely 
associated with CD4+ T cell depletion in the GALT, massive depletion of CD4+ T cells in peripheral 
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blood occurs during the acute phase of infection. Although this depletion is balanced through 
increased cellular immune activation and a proliferative response, in the ongoing process the hosts 
immune system constantly loses the ability to restock and fails to completely control viral replication. 
HIV escapes both cellular and humoral immune responses through its ability to mutate rapidly. 
 
In the chronic phase, continuing immune system activation, differentiation and exhaustion under 
persistent HIV viremia results in elevated cell turnover and transformations in cellular phenotype and 
function (Moir, Chun and Fauci et al., 2011). Eventually the infection reaches an advanced level in 
which the CD4+ T cell depletion is fulminant in the progression of infection, which results in AIDS 
(Moir, Chun and Fauci, 2011). The rising depletion of CD4 T cells correlates with the increasing loss 
of immune mediated control against opportunistic pathogens in AIDS, although timing of 
opportunistic infection is not necessarily related to the degree of the CD4 T cell loss, as some 
opportunistic infections can occur even in the presence of high CD4 T cell counts. Hence, HIV leads 
to a generalized immune dysfunction and a low immune reaction to opportunistic pathogens (Lane et 
al., 1983; Geldmacher and Koup, 2012).  
 
ART inhibits HIV replication to undetectable levels in peripheral blood but still cannot eradicate 
cellular reservoirs that had been latently infected before therapy started and thus fails to eliminate the 
virus completely. These latently infected reservoirs enable HIV to rebound when ART is interrupted 
through virus reactivation. LT is an important source of rebounding virus during treatment 
interruption (Rothenberger et al., 2015). Based on studies in peripheral blood, resting CD4+ memory 
T cells can be latently infected by replication competent virus. These cells have been suggested to go 
over a long-living quiescent state, hosting HIV provirus transcriptionally silent and immunologically 
inert, once they manage to get away from both cytotoxic CD8+ T cells as well as cytopathic viral 
effects. Therefore, they represent the fundamental origin of recrudescent infection and the main target 
for virus elimination (Chun et al., 1997a, b; Finzi, 1997; Wong et al., 1997).  
Earlier studies indicated that reservoirs from which infection rebounds after treatment interruption 
appear seem to originate either from persistent low-level virus production under lower concentration 
of antiretroviral drugs in LT or from latently infected cell reactivation (Estes et al., 2017). Although 
ART suppresses viral replication and decreases plasma viremia to the extend below sensitivity of 
clinical laboratory assay, lower drug levels were found in LT indicating incomplete suppression of 
viral replication, in comparison to the completely suppressive drug levels in peripheral blood 
(Fletcher et al., 2014; Rothenberger et al., 2015; Lorenzo-Redondo et al., 2016). Other parameters 
potentially contributing to ongoing infection include tissue fibrosis, gastrointestinal-tract damage, 
associated inflammation and CD4+ T cell depletion to a larger extend in advanced stages of infection 
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at the time of ART initiation (Schacker et al., 2002, 2005, 2006; Estes et al., 2008; Estes, Haase and 
Schacker, 2008). 
 
In a comparative study, mechanisms for HIV persistence during natural control was investigated in a 
rare cohort of elite virus controllers in the absence of ART (Walker and Yu, 2013; Migueles and 
Connors, 2015) characterized by very small frequencies of CD4 T cells hosting HIV DNA (Julg et 
al., 2010) and replication-competent HIV (Blankson et al., 2007) in contrast to non-controllers. In 
blood of controllers, provirus emerged clonally expanded within highly differentiated cells and at 
times expressed virions after stimulation. LT in this population was comprising numerous virus 
transcripts in T-follicular helper cells and other memory CD4+ T cell populations. Hence, this study 
revealed HIV persistence notwithstanding virological control through ongoing lymphatic cell 
infection, viability and recirculation of some of these cells as well as long-term remaining provirus 
in clonally expanded cells (Boritz et al., 2016). 
 
Consequently, the underlying mechanisms of HIV replication and persistence are not completely 
understood. Since viral replication and reactivation in latently infected, resting memory T-helper cells 
potentially enables HIV-1 persistence (Guenthard et al., 2000; Strain et al., 2003; Chun et al., 2005), 
current ART is not targeting these long-living cells for complete viral extirpation (Chun et al., 1997b; 
Wong et al., 1997; Finzi, 1997, Finzi et al., 1999; Blankson, Persaud, and Siliciano, 2002). However, 
it does reconstitute and protect memory CD4+ T cells from further HIV-induced depletion (Guadalupe 
et al., 2003; Brenchley et al., 2004a). Although ART thus reconstitutes immunity to the majority of 
opportunistic pathogens, its potential is still limited due to drug side effects, insufficient viral 
suppression and increasing drug resistance, which leads to the necessity to find solutions with long 
term curative approach. For these purposes an understanding of potential reservoirs as sources for 
viral rebound is mandatory.  
 
CD4+ T cells are essential for both supporting B-cells for efficient humoral immunity and supporting 
CD8+ T cells for cellular immunity to infections as well as immune system regulation. Mediated 
through various CD4+ T cell subsets these multiple helper functions are underlying a wide range of 
differentiation pathways (Zhu, Yamane and Paul, 2010). In general, lymphocytes are affected by HIV 
infection through activation increase, subpopulation differentiation, cellular debility, senescence and 
decreased rehabilitation potential. Intracellular viral loads of HIV DNA vary in different CD4+ T cell 
subsets arising by their differentiation level, (Brenchley et al., 2004b; Chomont et al., 2009; Ganesan 
et al., 2010) functional status (Casazza et al., 2009) and pathogen specificity (Douek et al., 2002; 
Geldmacher et al., 2010; Geldmacher and Koup, 2012). Therefore, various CD4 T cell populations 
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seem to differ in their susceptibility towards HIV infection and viral production.  
 
T cells consist of naive (antigen-naive) and memory (antigen-experienced) subsets. Memory T cells 
are divided into memory stem cells (TSCM), central memory T cells (TCM), transitional memory T 
cells (TTM) and effector memory T cells (TEM). Naive T -cells (TN) cells appear to be barely 
receptive to HIV infection. After activation TCM cells survive, proliferate and migrate into secondary 
LT, differentiate into TEM cells via T cell receptor crosslinking or infrequently in response to 
homeostatic cytokines. TEM cells present a major target of acute HIV infection and subsequent cell 
reduction in the mucosa. Functional and transcriptional features of TTM cells are in between TCM 
and TEM cells (Farber, Yudanin and Restifo, 2014). HIV associated immune dysfunction include 
impairment of T cell regeneration and differentiation, thymic function loss and LN damage. 
Analogues processes are ongoing in NK and B cells with resulting innate and adaptive (humoral) 
immune malfunction. Functional competence rather than the number of cells therefore plays a 
superordinate role (Moir, Chun and Fauci, 2011). In a study of Chomont et al. (2009) two main steady 
HIV reservoirs within memory CD4+ T cells had been identified comprising of TCM cells facilitating 
HIV persistence during ART due to their low cellular proliferation rate and intrinsic capacity to 
survive for decades (Combadiere et al., 2004; Riou et al., 2007) and TTM cells especially in patients 
with low CD4+ counts. Both TN and TEM seem to play a minor role in HIV reservoir provision 
during ART. An additional cellular long-term viral reservoir may be TSCM cells that are 
characterized by a high self-renewal potential and homeostatic proliferation and are also permissive 
to HIV infection (Gattinoni et al. 2011; Buzon et al., 2014). 
While cell activation status is oblique for viral replication it still remains unknown if distinct memory 
CD4+ T cell populations play a major role in active virus replication and production or if diverse cell 
populations may be responsible for ongoing plasma virus contribution.  
CD4+ T cells often downregulate CD4 as an effect of productive HIV infection. Hence, productively 
infected CD4 T cells may be enriched in the CD4-/CD8- memory T cell population. Therefore, cells 
with CD4 low or no surface expression may represent the majority of productively infected cells 
expressing HIV-RNA and further the predominant cell type supporting ongoing HIV-1 production in 
peripheral blood or LT (Kaiser et al., 2007). Furthermore, CD4 T cell susceptibility by HIV is affected 
by cellular activation levels and viral entry receptor expression as well as functional characteristics, 
such as cytokine and chemokine synthesis, (Geldmacher and Koup, 2012).  
 
CD45, a tyrosine protein phosphatase is regulating the src family kinases, key regulators of signal 
transduction. CD45RA is expressed on naive CD4 T cells and effector cells while CD45RO represents 
a memory marker in CD4+ T cells. Furthermore, in HIV infected subjects, central and effector 
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memory T cells gain expression of CD45RO and lose expression of CD45RA during antigen 
stimulation (Pinto, Covas and Victorino, 1991).  
 
Interleukin-2 (IL-2) is a cytokine that drives antigen-specific T cell proliferation and survival. 
Memory CD4+ T cells expressing the interleukin 2 (IL-2) receptor alpha chain (CD25) are known to 
facilitate efficient HIV infection in LT. In contrast, in vitro productive HIV infection seems to be 
almost completely suppressed, when IL-2 signaling is being intercepted (Finberg et al., 1991; Ramilo 
et al., 1993; Goletti et al., 1996; Chou et al., 1997; Boyman and Sprent, 2012). Hence, CD25+ CD4+ 
T cells were suggested early on to actively produce virus (Ramilo et al., 1993; Borvak et al., 1995). 
 
A high proportion of CD25+ memory CD4+ T cells co-express the transcription factor forkhead box 
P3 (FoxP3), designated regulatory T cells (Tregs). FoxP3 is essential for the development and 
function of CD25+ Treg cells (Fontenot, Gavin, and Rudensky, 2003; Hori, Nomura and Sakaguchi, 
2003; Khattri et al., 2003), which are known to mediate suppressive effects on T and B cells 
(Sakaguchi, 2004). To prevent over-reactive immunity, Tregs play a crucial role in immune response 
modulation. Tregs are capable to migrate into secondary LT and suppress B-cell antibody responses 
directly (Lim et al., 2005). 
Nuclear factor of activated T cells (NFAT) are transcription factors in lymphocytes involved in the 
gene expression regulation of cytokines, such as IL-2. Various mechanisms had been identified in 
which FOXP3 inhibits NFAT responsive gene expression. This includes transactivation or repression 
of NFAT target genes (Zheng and Rudensky, 2007), inhibition of transcriptional activity, modulated 
by NFAT and nuclear factor „kappa-light-chain-enhancer” of activated B-cells (NfκB) (Bettelli, 
Dastrange, and Oukka, 2005). FoxP3 further suppresses transcription activity through forkhead 
binding site interaction (Wu et al., 2006; Marson et al., 2007).  
 
Controversial findings in Treg numbers in HIV patients had been described in various studies with 
either an increase (Andersson et al., 2005; Epple et al., 2006; Nilsson et al., 2006; Estes et al., 2006) 
during HIV infection or decrease (Oswald-Richter et al., 2004; Kinter et al., 2004; Apoil et al., 2005; 
Eggena et al., 2005; Tsunemi et al., 2005) possibly depending on the stage of infection, immune 
activation status and viral load. However, during acute HIV infection Tregs may function as 
competent target cells for HIV infection whereas chronification of HIV infection is associated with a 
cumulative depletion of this cell subset (Holmes, Zhang and Su, 2008).  
 
Tfh cells are a specialized CD4 T cell subset defined by cell surface expression of programed death 
receptor 1 (PD-1) and the homing receptor for B Cell follicles, CXC chemokine receptor 5 (CXCR5) 
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(Fazilleau et al., 2009; Qi, 2016). By facilitating signals to B-cells in germinal centers (Gcs), Tfh cells 
induce B-cell proliferation, isotype switching, somatic hypermutation and affinity maturation during 
immune responses and contribute to long-lived plasma cell and memory B-cell responses (Mueller, 
Hoepkin and Lipp, 2003; Crotty, 2014, 2015). For differentiation Tfh cells are depending on dendritic 
cell (DC) priming of naive antigen-specific CD4 T cells (Crotty, 2011, 2012; Webb and Lintermann, 
2017). Resulting from the challenges of studying LT in humans, investigations were depending 
increasingly on peripheral Tfh cells, a memory CD4+ T cell subset similar to LN Tfh cells. These 
peripheral Tfh cells express the B-cell follicular homing molecule CXCR5 but show moderate PD-1 
levels (Akiba et al. 2005; Morita et al., 2011; Nicholas et al., 2016; Schultz et al., 2017). By 20-25% 
CXCR5 is expressed of peripheral blood human central memory CD4+ T cells but its function is still 
not completely understood (Chevalier et al., 2011). Stable levels of peripheral Tfh levels however are 
considered to be essential for continuing immune system functionality. Tfh cells are infected by 
follicular DCs transporting infectious HIV virions into lymphatic organs and are considered to 
function as a predominant viral reservoir with integrated HIV genomes (Vinuesa, 2012; Perreau et 
al., 2013; Fukazawa et al., 2015; Boritz et al., 2016). In contrast to the GC Tfh cell expansion a 
remarkable peripheral Tfh decrease had been detected in the chronic course of HIV infection 
(Pallikkuth, Fischl and Pahwa et al., 2013; Boswell et al., 2014). Further low CD4 T cell counts during 
HIV infection seem to be accompanied with significantly decreased CXCR5 levels and hence B-cell 
immunopathology, which leads to impaired humoral immunity under disease progression (Chong et 
al., 2004; Cagigi et al., 2008). 
PD-1 is a cell surface receptor functioning as a down-regulator of the immune system and 
inflammation, which contributes to self-tolerance. Hence, PD-1 leads to balanced surveillance against 
autoimmune processes by stimulating apoptosis in antigen specific T cells in LN and 
contemporaneous repressing apoptosis in regulatory T cells (anti-inflammatory, suppressive T cells; 
Francisco, Sage and Sharpe, 2010; Fife and Pauken, 2011). Immune cell exhaustion had been noticed 
in multiple persisting viral infections. PD-1 signaling is linked to virus-specific T cell exhaustion. 
PD-1+ memory CD4+ T cells during HIV were detected to have higher levels of HIV-1 DNA than 
other memory T cell subsets, based on studies of PBMCs (Chomont et al., 2009; Perreau et al., 2013). 
Amongst ART disruption the PD-1 expression on PBMCs correlates with plasma viremia relapse 
(Hurst et al., 2015). In contrast suppression of PD-1+ CD8+ initiation leads to survival and effector 
response increase against HIV (Moir, Chun and Fauci, 2011). CD4 T cells corresponding to Tfh cell 
populations, thus CXCR5+PD-1+ and CXCR5-PD-1+ cells, were found to be significantly enriched in 
distinct HIV specific CD4 T cells and Tfh cells. Both had been reported to contain the highest viral 
levels of HIV-infected cells and therefore may represent a predominant virus replication and 
production site (Perreau et al., 2013).  
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Ki67 presents a marker for in vivo cell proliferation activity and provides an indirect measurement of 
HIV infection related proliferation in the different CD4 T cell subsets. Increased Ki67+CD4+ T cell 
levels had been reported in patients suffering from HIV in both LT (Tenner-Racz et al., 1998) and 
PBMCs (Sachsenberg et al., 1998), in particular during primary HIV-1 infection. 
 
It remains largely unknown which HIV-infected cell populations contribute to plasma viremia. 
Abundance of viral RNA in CD4-/CD8- T cells from viremic patients observed in a previous study 
(Kaiser et al., 2007) supports the hypothesis that especially the CD4low and CD4- subsets are a major 
cell population contributing to plasma virus production. To investigate whether such a particular cell 
subset contributes to ongoing plasma virus production, we analyzed the HIV highly variable envelope 
EnvV1V3 region in 4 different memory T cell populations and in plasma from 9 viremic patients for 
phylogenetic comparisons. Under the assumption that quasi-identical pairs of cell-derived and 
plasma-derived nucleotide sequences may provide evidence that a specific cell subset recently 
participated in plasma virion production or became recently infected we analyzed memory T cell 
populations delineated into CD4low/- and CD4+ subsets. CD4+ memory T cells were further delineated 
into Tregs (CD25+/FoxP3+) and non-Tregs (CD25-/FoxP3-). Non-Tregs were further delineated into 
Tfh cells (CXCR5+) and non-Tfh cells (CXCR5-).  
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Study subjects belonged to the large high-risk cohort of 600 female bar workers, who had enrolled 
in a prospective study of HIV-1 superinfection (HIV Superinfection Study [HISIS]) in the Mbeya 
region of Southwest Tanzania. Blood samples were taken, after giving consent, at enrollment 















The HIV-1 status was determined using HIV enzyme-linked immunoassay tests (Enzygnost Anti 
HIV1/2 Plus, Dade Behring, Liederbach, Germany and Determine HIV ½, Abbott, Wiesbaden, 
Germany). Discrepancies in the results were resolved by using the Western blot assay (Genelabs 
Diagnostics, Geneva, Switzerland). Plasma HIV-1 RNA levels were measured with the Amplicor 
HIV-1 Monitor assay (Roche Diagnostics Indianapolis, IN; Geldmacher et al., 2007b).  
9 antiretroviral naive, HIV positive subjects were selected for this study at Follow up 12 (36 
months after enrollment). Three of these 9 subjects had seroconverted in the progress of the study. 
Subtype identification and dual infection evidence was determined (Table 1) by MHA (Multi 
hybridization assay; Hoelscher et al., 2002). 
Ethical approvals were obtained from the Mbeya Regional and National Ethics Committees of the 
Tanzanian National Institute for Medical Research (NIMR)/Ministry of Health in Dar es Salaam, 
Tanzania and from the ethics committee of the University of Munich.  
Table 1 Infection status, subtype and dual infection evidence for the 9 subjects of the HISIS cohort at 
Follow up 12 (36 months after participant enrollment) 
 
Subject Infection status by the time of blood  
sample collection 
Subtype Dual infection evidence 
  H442                  21-24 months    AC                  Dual 
  H76                     >36 months       C                 Single 
  H457                     >36 months       C                 Single 
  H533                     >36 months       CD                  Dual 
  H293                     >36 months       C                 Single 
  H304                  30-33 months        C                 Single 
  H446                     >36 months       C                 Single 
  H241                     >36 months    ACD                  Dual 




2.2 Cell preparation 
 
40 ml of venous blood was drawn from each participant by using CPDA (citrate phosphate 
dextrose adenine) anticoagulant tubes and processed within less than 6 hours after blood draw as 
described previously (Geldmacher et al., 2007a). Plasma samples were collected after 
centrifugation. PBMCs (Peripheral blood mononuclear cells) were isolated by centrifugation on a 
Ficoll-Hypaque (Biocoll separating solution; Biochrom AG, Berlin, Germany) density gradient. 
PBMCs and plasma samples were cryopreserved in liquid nitrogen and -80°C respectively before 
usage in this study.  
 
2.3 PBMC- and Plasma staining for Fluorescence activated cell sorting (FACS) 
 
The following steps had been performed in a S3** laboratory carried out in a laminar flow safety 
cabinet which enabled a save and coordinated processing to all specimen and applying safety 
instructions for bloodborne pathogens in the S3** risk group. 
 
2.3.1 Thawing process and cell quantification  
 
In a first step complete media, consisting of 500 ml RPMI medium 1640 (1X; GibcoTM 
GlutaMAXTM), 50 ml heat inactivated FCS from PAA (inactivated fetal calf serum) and 5ml Pen 
Strep from Sigma, was prepared. 
Thawing media was prepared with 4 µl Benzonase per 20 ml complete media. Frozen PBMCs 
were thawed in a 37°C water bath and then dropwise diluted with 10 ml of thawing media. After 
centrifugation of 400xg for 5 minutes, which remained the adjustment for all centrifugation steps 
for FACS preparation, supernatant was discarded, the pellet resuspended in the remaining thawing 
media and centrifugation was repeated. Supernatant was discarded and the pellet diluted in 2 ml 
complete media for cell counting. An aliquot of this suspension was stained in a 1:10 dilution with 






2.3.2 Antibody staining panel for flow cytometric cell sorting 
 
In order to identify different memory CD4+ T cell populations, a staining panel was developed 
using QA/QC PBMC. The full antibody-fluorochrome panel consisted of 9 markers (Table 2). 
Fluorochrome labelled antibodies were titrated from 5 µl, 2.5 µl, 1.25 µl, 0.625 µl and 0.3125 µl 
each to achieve optimal PBMC staining results, defined by the best separation between marker 













2.3.3 Cell staining with conjugated fluorochrome antibodies 
 
The remaining suspension was centrifuged, supernatant discarded and the pellet stained with the 
first fluorochrome antibody panel regarding the optimized titration values including CD3, CD4, 











Table 2 Full antibody-fluorochrome panel including 9 markers binding various fluorochromes 
 
Marker Fluorochrome 
 CD3        FITC anti-human from BioLegend 
 CD4        ECD from Bechman Coulter Inc. 
 CD8        APC-Alexa Fluor 750 from Beckman Coulter Inc. 
 CD25        Brilliant Violet 605 anti-human from BioLegend 
 CD45RA        Brilliant Violet 421 anti-human from BioLegend 
 PD1 (CD279)        PC5.5 from Beckman Coulter Inc. 
 CXCR5 (CD185)        PECy7 from BioLegend 
 Ki67        PE from BioLegend 
 FOXP3        Alexa Fluor 647 from Beckman Coulter Inc. 
 
Fluorochrome antibody marker Volume in µl 
                    CD3 FITC            1.25 
                    CD4 ECD            1 
                    CD8 APC AF750            0.5 
                    CD25 BV 605            1.25 
                    CD45RA BV 421            2 
                    PD1 PC5.5            0.625 
                    CXCR5 PECy7            0.625 




During a 25 minutes incubation in darkness, Fixation/Permeabilization buffer from eBioscience 
was prepared from Fixation/Permeabilization concentrate and Fixation/Permeabilization diluent 
in a 1:4 dilution and another Permeabilization Buffer with a concentrate from eBioscience and 
double distilled water in a 1:10 dilution. After incubation samples were washed with FACS wash 
buffer (1:25 dilution of 2% FCS in RPMI medium 1640) and centrifuged. The supernatant was 
discarded and the pellet resuspended in Fixation/Permeabilization buffer and incubated for 30 to 
60 minutes in darkness. Permeabilization buffer was then added to each sample. Centrifugation 
was repeated and supernatant discarded. To enhance the cell isolation, filter paper was used to 
absorb the residual buffer before adding the fluorochrome antibodies Ki67 and FoxP3 (Table 4) 








Another washing step with Permeabilization buffer followed. The dilution was centrifuged, 
supernatant discarded and the pellet diluted in Flow cytometry fixation buffer (Table 5). The Flow 
cytometry fixation buffer was prepared in a 1:10 dilution with distilled water, while the cells 











The full antibody panel was compensated to prevent staining artefacts from overlapping 
fluorochrome emission spectra. Individual antibody staining was performed on 1 drop of Versa 
Comp positive control beads (VersaComp Antibody Capture positive beads from Beckman 
Fluorochrome antibody marker Volume in µl 
                        Ki67 PE             1.25 
                        FoxP3 AF647             2.5 
 Table 4 Optimized titration values for the Fluorochrome antibody markers 
Cell quantity Flow cytometry fixation buffer in µl 
            <1x106 150 
  1x106 - 5x106 250 
  5x106 - 107 350 
      107 - 3x107 500 




Coulter Inc.) and a negative control bead (BD CompBeads negative control from Beckman Coulter 
Inc.) Each of these stained beads was acquired to set up the compensation matrix before 
fluorescence activated cell sorting.   
 
2.4 Fluorescence activated cell sorting (FACS) 
 
In cooperation with the Institute of Virology, Faculty of Medicine at the Technical University of 
Munich, the fixed cells were sorted using a FACS Aria III cell sorter from Becton, Dickinson and 
Company BD Bioscience to sort the populations of interest including CD4low/-, CD25+/FOXP3+, 
CXCR5+ and CXCR5- cells. Sorted populations, constantly preserved on ice in between further 
processing, were centrifuged at 17900xg for 3 minutes. The entire supernatant was discarded and 
the pellet stored at -80°C.  
 
For FACS analysis the gating tree for the populations of interest had been analyzed using FlowJo 
version 10.1r5. From lymphocytes, only singlet cells were selected leaving duplets, triplets and 
larger cell clusters behind. Single lymphocytes were separated by gating only CD3+ cells and 
further only the CD45RA- cell subset of latter population. From the CD45RA- cell subset 
CD4+CD8- and CD4low/- and CD8- cells were gated. The CD4low/- cell population was sorted while 
the CD4+ cell subset was further separated into CD25+/FoxP3+ and CD25-/FoxP3-. The 
CD25+/FoxP3+ population was sorted and the CD25-/FoxP3- population was further distinguished 
into CXCR5+ and CXCR5- subsets, while both of them were sorted. 
 
2.5 Amplification and phylogenetic comparison of HIV envelope sequences from plasma 
and sorted cell populations 
 
2.5.1 Cell lysis 
 
For cell lysis, the pellet was resuspended in 10mM TRIS-HCl buffer (pH 8), made from molecular 
biology grade pre-made 1M TRIS-HCl buffer (Trizma hydrochloride buffer solution, Sigma) and 
a 100 µg/ml proteinase K (Roche). For every 105 cells 10 µl of latter diluent was layered above 
the sorted pellet. If the cell number was below 3x105 still a minimum of diluent of 30 µl was used, 
which was applied for the majority of the sorted cell populations. The suspension was carefully 
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vortexed and subsequently incubated for a minimum of 1 hour at 56°C. Again, vortexed and briefly 
centrifuged at 17900xg for a few seconds, the suspension was then incubated another 10 minutes 
at 95°C to inactivate the proteinase K. To relieve the cell debris from the bottom the suspension 
was vortexed and centrifuged for 30 seconds, with the same settings as earlier. 
 
2.5.2 Nested Polymerase chain reaction (PCR) 
 
In advance (in cooperation with the Institute of Virology, Faculty of Medicine at the Technical 
University of Munich), HIV cDNA from 3µl extracted plasma RNA was synthesized using the 
reverse primer ACD_Env7521R (5'ATGGGAGGGGCATAYATTGC) and the Superscript III 
reverse transcriptase (Life Technologies, Darmstadt, Germany) according to the manufactures 
instructions and as described previously (Chachage et al., 2016). 
 
A nested PCR was used to amplify the highly variable envelope region of V1 to V3 (EnvV1V3; 
Hxb 6559 to 7320) from the previously synthetized cDNA of plasma RNA and DNA of the sorted 
cell populations. On behalf of this method non-specific binding due to amplification of 
uncalculated primer binding sites could be reduced. In this two-round PCR the second round 
amplified the target region on the first-round template. For the detection of the subtypes A, C and 
D PCR primer pairs had previously been optimized to amplify the EnvV1V3 region (Chachage et 
al., 2016). All primers for the nested-PCR were diluted in a proportion of 100pmol/µl with water 
molecular biology reagent and stored at -20°C before usage. 
 
The first-round PCR was performed with 10µl template (supernatant from lyses cells, refered to 
2.5.1) in a 50µl reaction mixture, including water molecular biology grade (Sigma-Aldrich), 
deoxynucleotide trisphosphates (dNTPs 100mM, Thermo Scientific), 10x Rxn buffer (from 
Invitrogen), MgCl2 50mM from Invitrogen, primer Env 6420 F 
(5'CATAATGTCTGGGCYACACATGC; Thermo Scientific), primer Env 7521 R 
(5'ATGGGAGGGGCATAYATTGC; Thermo Scientific) and Platinum Taq Polymerase 



















The second-round PCR was performed with 5 µl of the first-round product in a 50 µl reaction 
mixture (Table 7), including the same contents as for round one and the primers Env 6559 F 
(5'GGGAYSAAAGCCTAAARCCATGTG; Thermo Scientific) and Env 7320 R 
(5'GTTGTAATTTCTRRRTCCCCTCC; Thermo Scientific). 
 
For both rounds a Thermocycler, TProfessional Standard from Biometra was used. The 
polymerase was activated for 10 minutes at 95°C and amplified for 41 cycles (30 seconds at 94°C, 
30 seconds at 53°C and 1 minute and 30 seconds at 72°C) followed by a final elongation step of 7 














3 µl of the second PCR reaction were resuspended in 7 µl Blue Juice to screen for the amplicon of 
interest using gel electrophoresis by use of a 250 base pair (bp) DNA ladder from Invitrogen. The 
Nested PCR reaction components Volume in µl 
   Water molecular biology reagent          19 
   dNTPs 100mM            4 
   10x Rxn buffer             5 
   MgCl2 50mM             3.5 
   Primer Env 6420 F            4 
   Primer Env 7521 R            4 
   Platinum Taq Polymerase            0.5 
   Total          40 
 Table 6 First-round PCR reaction content proportions 
 
Nested PCR reaction components Volume in µl 
   Water molecular biology reagent          28.25 
   dNTPs 100mM            4 
   10x Rxn buffer            5 
   MgCl2 50mM            3.5 
   Primer Env 6559 F            2 
   Primer Env 7320 R            2 
   Platinum Taq Polymerase            0.25 
   Total           45 




PCR product imaging after gel electrophoresis was visualized through Grab-IT, Version 2.59. 
As the deployed Taq Polymerase didn't include proof reading the positive-control template Du422 
(clone 1 [SVPC5]; Li et al., 2006) was endpoint diluted equal to Chachage et al. (2016) to evaluate 
the error rate of the nested-PCR on behalf of a 10-fold-dilution series and amplified as described 
earlier. From the last detectable dilution step the EnvV1V3 product was then cloned as described 
earlier. The sequences of 21 clones had been analyzed and compared to the original Du422 
template sequence. The variability appeared to be in a minimal extend of only 0-4 base pare errors 
through nested-PCR processing and therefore, quasi-identical assumption was assumed within this 
range at the Chachage et al. (2016) study and was transferred to this study.   
 
2.5.3 Gel Extraction 
 
According to the protocol by the manufacturer the Qiagen Gel extraction kit was used to extract 
the 760 bp EnvV1V3 amplicon from the Gel according to manufacturer instructions. Depending 
on the resulting DNA quantity 10 µl up to 47 µl of the second-round PCR product were 
resuspended in Blue Juice in a 1:10 ratio in favor for the product and transferred to gel 
electrophoresis. A 250 bp ladder was used to identify the region of interest. To avoid DNA 
contamination the entire equipment used was decontaminated with 2% hypochlorite solution 
(Merck). Precisely the 760 bp bands were selectively excised out with a scalpel, the gel slice 
weighted and suspended in QG solubilization buffer (QIAquick) in a proportion of 3 volumes 
buffer to 1 volume gel (100 mg gel∼100 µl). This suspension was left at 50°C for 10-15 minutes 
until it was completely diluted. Next, 1 volume gel Isopropanol (2-Propanol molecular biology 
grade, AppliChem) was resuspended.  
The entire volume was disposed into QIAquick spin columns, each no more than 400 mg of gel 
volume. For cloning 500 µl QG solubilization buffer was added to each column, the whole 
suspension centrifuged at 17900xg for 1 minute and the supernatant discarded.  
Subsequently, 750 µl PE wash buffer was added to each QIAquick spin columns. To use the DNA 
for salt sensitive cloning, the columns were incubated for 2-5 minutes after buffer addition, 
centrifuged twice with the same setting as before and supernatant discarded to remove residual 
wash buffer. The columns were transferred to new microcentrifuge tubes. For DNA extraction 50 
µl water molecular biology reagent (from Sigma) was added to the center of the QIAquick 
membrane. To increase the yield of purified DNA, the suspension was incubated for 2 minutes 
before centrifugation. To proof successful extraction 5 µl of the DNA suspension was tested again 
on gel electrophoresis. 
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2.5.4 Cloning reaction of purified DNA fragments 
 
The TOPO cloning kit (Invitrogen by Life Technologies, Darmstadt, Germany) was used for 
cloning. 0.5 µl salt solution (1.2 M NaCl and 0.06 M MgCl2) and 0.5 µl TOPO (PCR 4-TOPO 
vector), including the precut plasmid vector pCRTM 4-TOPO were added to 2 µl of the before 
extracted DNA fragment and incubated for 15 minutes at room temperature. The reaction was put 
on ice and 25 µl of One Shot TOP10 chemically competent E.coli (Invitrogen) were added, gently 
mixed and incubated for 20 minutes, remaining on ice. Next, the suspension was heat-shocked at 
42°C for 30 seconds and replaced on ice afterwards. 250 µl of room temperature S.O.C medium 
was added and the entire suspension shaken for 60 minutes. 50 µl of each transformation was 
spread on an ampicillin plate and left in an incubator at 37°C overnight for approximately 18 hours. 
 
After the 18 hours incubation time clones were picked and resuspended in 2 ml of LB ampicillin 
medium (containing 100 µg/ml ampicillin) and cultured overnight at 37°C on a shaker for 
approximately 18 hours again. The plates were wrapped with Parafilm, when clones were left and 
stored at 4°C, if further clones were needed. 
 
2.5.5 Plasmid preparation 
 
The PureLink Quick Plasmid MiniPrep Kit of the TOPO cloning kit (Invitrogen by Life 
Technologies, Darmstadt, Germany) was used for plasmid preparation. The overnight 2 ml 
cultures were centrifuged at 6800xg for 3 minutes, supernatant was discarded and the remaining 
supernatant removed with filter paper. After resuspension, 250 µl Buffer P1 (RNase A Buffer) and 
250 µl buffer P2 (lysis buffer) was added and the suspension shaked 4-6 times within less than 5 
minutes. Another 350 µl of buffer N3 (neutralization buffer) was added and again everything 
shaked 4-6 times. The whole suspension was centrifuged at 17900xg for 10 minutes. From the 
supernatant 800 µl were transferred to a new spin column, centrifuged at 17900xg for 
approximately 30-60 seconds and supernatant discarded. 500 µl of buffer PB (binding buffer) was 
added, centrifuged for 30-60 seconds with the same setting as latter and supernatant discarded. 
750 µl of buffer PE (wash buffer) was added and again the same centrifugation and supernatant 
discard followed. Another centrifugation at 17900xg for 1 minute was performed to remove 
residual wash buffer. The columns were displaced to new tubes and 50 µl water molecular biology 
reagent (from Sigma) was added and everything incubated for 2 minutes before a further 
centrifugation at 17900xg for 1 minute.  
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2.5.6 Verification of cloned insert 
 
To proof the successful cloning, the restriction enzyme EcoRI (10U/µl, Fermentas) was used to 
verify the insert of interest. The mastermix was prepared including 3.5 µl water molecular biology 
reagent (Sigma), 1 µl 10x EcoRI buffer (restriction buffer) and 0.5 µl EcoRI.  
5 µl of the DNA extract was resuspended in 5 µl mastermix and incubated at 37°C for 90 minutes. 
From this suspension, another control gel electrophoresis was performed to proof for the amplified 
sequence at 760 bp. 
 
2.5.7 Molecular Sequencing 
 
16 to 27 EnvV1V3 containing clones per cloning reaction from up to 5 compartments (different 
cell subsets or plasma) were sequenced unidirectional using M13rev primers at Eurofins Genomics 
(Ebersberg, Germany). Collectively 621 EnvV1V3 sequences from 9 subjects were analyzed. 
 
2.5.8 Phylogenetic comparison of HIV envelope sequences from Plasma and sorted cell 
subsets 
 
Individual EnvV1V3 sequences from each clone and subset were analyzed for each individual 
using MEGA version 6.06. Regarding to the predicted nucleotide sequence of the reference 
alignment extracted from the Los Alamos HIV database 
(http://www.hiv.lanl.gov/content/sequence/NEWALIGN/align.html) nucleotide sequences were 
aligned as former described (Pollakis et al., 2015). The alignments were manually corrected by 
complementation and primer cut off. 
 
In cooperation with Dr. Georgios Pollakis at the Department of Clinical Infection, Microbiology 
and Immunology (CIMI), the NIHR Health Protection Research Unit in Emerging and Zoonotic 
Infections (HPRU EZI) at the Institute of Infection and Global Health (IIGH) in Liverpool the 
evolutionary history was inferred on behalf of the maximum likelihood method based on the 
general time-reversible substitution model (GTR+G; Nei and Kumar, 2000) and was rooted in 
previous outbreaks. The tree with the highest log likelihood is presented for each analysis. Next to 
the branches the percentage is presented in which the associated taxa clustered together. For the 
heuristic search the initial tree(s) was/were obtained automatically by applying neighbor-joining 
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and BioNJ algorithms to a matrix of pairwise distances, estimated using the maximum composite 
likelihood (MCL) approach and further selecting the topology with superior log likelihood value 
(Fig. 3, Fig. 4).  
 
The nucleotide variation of plasma to the cell population of interest (Fig. 5 and Fig. 6) was plotted 
using Prism Version 4.0 software (GraphPad, Inc.) including the interquartile range of 25% to 75% 
with the mean distance for each participant. 
 
For identification of quasi-identical sequences, the phylogenetic maximum likelihood tree analysis 
in MEGA 6.06 was examined in order to find clusters of plasma-derived sequences with cell-
derived sequences. Subsequent manual counting of nucleotide differences between those 
sequences enabled to proof for quasi-identical or close to quasi-identical clusters as defined by the 




















For the phylogenetic characterization of HIV EnvV1V3 sequences within the sorted memory T cell 
populations, PBMCs of 9 viremic HIV positive female individuals from the HISIS cohort were 
analyzed in this study. These patients were HIV infected between 21 to over 36 months, a median 
















    H442  463            51200 
    H76  227            15800 
    H457  348        >750000 
    H533  473              5890 
    H293  253          Not available 
    H304  350            69200 
    H446  143          258000 
    H241 359          Not available 
    H346 251          119000 
 
Table 8 CD4+ T cell counts (cells per µl) and viral load (copies per 



















After thawing, 6 to 36 million cells with a median of 9.75x106 PBMCs per 2 ml were counted to 

















Subject Number of counted PBMCs / 2 ml 
    H442                               10.9    x106 
    H76                                 6.15  x106 
    H457                                 9.75  x106 
    H533                               13.5    x106 
    H293                               36.3    x106 
    H304                               18       x106 
    H446                                 9.5    x106 
    H241                                8.3    x106 
    H346                                7.7    x106 
 Table 9 Quantities of cells for each subject after PBMC thawing process 




3.3 FACS  
 


































Plasma virus sequences were phylogenetically compared with cell-derived sequences of CD4low/-, 
CD4+CD25+/FoxP3+, CD4+CXCR5+ and CD4+CXCR5- memory T cell subpopulations. 
Primarily from all detected monocyte cells, selectively lymphocytes, in particular only singlets were 
Fig. 1 Representative gating tree during cell sorting. Lymphocytes were gated from all monocyte cells as shown for 
subject H442 from which only singlets with an amount of about 99% were selected. About 75% of T-lymphocytes 
(CD3+ cells) were selected from singlets and further divided into naive (CD45RA+) and memory T cells (CD45RA-), 
latter with about 73%. From the memory T cells the CD4low/- population with approximately 5% was sorted. From 
CD4+ T cells, Tregs (CD25+/FoxP3+) with about 4% were sorted. The CD25-/FoxP3- cells were then distinguished and 
separately sorted into Tfh containing cells with about 27% (CXCR5+) and non-Tfh cells (CXCR5-) with 71% 
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gated, excluding duplets, triples and larger cell clusters. The gated singlet T-lymphocytes (CD3+) 
were separated from other cell populations, such as dendritic cells, natural killer cells and B-
lymphocytes and divided into naive (CD45RA+) and memory T cells (CD45RA-). From the memory  
T cell population CD4low/-/CD8- cell subsets were sorted. From the CD4+/CD8- cell population Treg 
cells (CD25+/FOXP3+) were sorted and non-Treg cells were further separately sorted by dividing 
them into Tfh cells (CXCR5+) and non-Tfh cells (CXCR5-; Fig. 1).  
 















From the 6 up to 36 million cells per 2 ml that had been counted after thawing (Table 9), 
approximately 2x103 to 7.8x105 cells were sorted for the 4 subpopulations of interest for each subject 
(Table 10). For the CD4low/- subset the median over all subjects was 81945, for the CD25+/FOXP3+ 
subject 10153, for the CXCR5+ subset 62813.5 and for the CXCR5- subset 205275.5 (Table 10). 
 
3.4 Amplification of EnvV1V3 DNA using a nested PCR 
 
Values for the subpopulations that had not been successfully amplified for the EnvV1V3 region 
(black colored values) and values for the subpopulations that had been successfully amplified for the 
EnvV1V3 region (blue colored values) are presented in Table 10. 
 
Subject CD4 low/- CD25+/FoxP3+ CXCR5+ CXCR5- 
    H442       2.8x105          18175       2.8x105      7.8x105 
    H76        80000         4.6x104       3.4x105      4.9x105 
    H457       1.8x105         1.9x104       1.1x105      2.8x105 
    H533       1.4x105          10153        64769     3.2 x105 
    H293       2.9x105          36246        62066     2.2 x105 
    H304        81945          43645        85053       17047 
    H446        31940            6905        20024       92665 
    H241        57348            7743          2211     1.8 x105 
    H346       84272            8935        63561      2.2x105 
 Table 10 Quantities of all sorted populations of interest for each subject in absolute 
numbers. Quantities of the sorted populations of interest without successful EnvV1V3 
amplification are colored in black, sorted populations of interest with successful EnvV1V3 






















The 760 bp target sequence of EnvV1V3 was successfully amplified on behalf of nested PCR 
processing within the V1 to V3 region of Hxb 6559 to 7320 for all of the 9 subjects in diverse 
distribution within the 4 cell populations of interest (Fig.2, Table 10). Particularly for Treg cells the 
EnvV1V3 could be amplified and sequenced for 7 out of 9 subjects. For the Tfh cells and non-Tfh 
cell populations EnvV1V3 was detected for both in 6 out of 9 subjects. An EnvV1V3 amplicon was 












Fig. 2  The EnvV1V3 sequence, comprising approximately 
760 bp, was verified in all subjects in various 














































Fig. 3 Phylogenetic relationship of clonal EnvV1V3 sequences derived from plasma and from CD4low/-, 
CD4+CD25+/FoxP3+, CD4+CXCR5+ and CD4+CXCR5- cell subsets. Phylogenetic distances between various 
subpopulations in percent are presented with individual probability estimations of the distribution marked on 
the phylogenetic branches. Plasma-0 represents the very early stage of infection, less than 3 months after 




The individual phylogenetic trees of each subject visualize the genetic variations of clonal EnvV1V3 
sequences within plasma at the early stage of infection, specifically the first seropositive follow-up, 
less than 3 months after infection with a primarily seronegative status (Plasma-0; H304, H346 and 
H605; Fig. 3, Fig. 4), within plasma at Follow up 12, between plasma to cell and within variations of 
the selected cell populations. With a probability estimation between 80 up to 100 the phylogenetic 
distribution is represented for each subject (Fig. 3). Clusters of the CD4low/- -derived sequences with 
plasma-derived sequences were found in 2 of the 9 subjects including a cluster of 3 CD4low/- derived 
sequences quasi-identical with 4 plasma populations (H76; Q1; Fig. 3; Table 11) and 1 CD4low/- 
derived sequences quasi-identical with 1 plasma population (H442; Q5, Fig. 3; Table 11). The largest 
quasi-identical pair was detected for the CD25+/FoxP3+ subset with 17 cell-derived sequences 
clustering with 2 plasma-derived sequences (H241; Q2; Fig. 3; Table 11). 1 quasi-identical pair was 
detected for 1 Tfh (CXCR5+) cell-derived sequence clustering with 1 plasma derived sequence (H304; 
Q3; Fig. 3; Table 11). Most quasi-identical pairs were detected for non-Tfh (CXCR5-) cells with a 
large cluster of 1 cell-derived sequence with 10 plasma-derived sequences (H442; Q4; Fig. 3; Table 
11), 2 clusters of 1 cell-derived sequence with 1 plasma-derived sequence (H304; Q3 and H446; Q6; 
Fig. 3; Table 11) and 1 cluster of 2 cell-derived sequences with 1 plasma-derived sequence (H446; 
Q7; Fig. 3; Table 11). No quasi-identical clusters could be detected for 4 subjects (H457, H533, H293 





















Subject Plasma CD4 low/- CD25+/FoxP3+ CXCR5+ CXCR5- Quasi-identical pair number 
  H76       4  3(1-3S)        0     0    0 Q1 
  H241       2  0      17(0-3S)     0    0 Q2 
  H304       1  0        0     1(3S)    1(3S) Q3 
  H442     10  0        0     0    1(4S) Q4 
      1  1(4S)        0     0    0 Q5 
  H446       1  0        0     0    1(3S) Q6 
      1  0        0     0    2(3S) Q7 
  H457       0  0        0     0    0  
  H533       0  0        0     0    0  
  H293       0  0        0     0    0  
  H346      0  0        0     0    0  
 Table 11 Quantities of quasi-identical plasma-derived sequences and distinct cell-derived sequences selectively for the 
4 investigated subpopulations. No quasi-identical clusters could be detected for the 4 grey highlighted subjects. The 




With the endpoint diluted molecular clone of the subtype isolate Du422 clone 1 the PCR-related 
sequence background variation was controlled. The 21 Du422 sequences contained either 0, 1 or 2 
nucleotide substitutions, neither insertions nor deletions in 95% of the amplicons. Hence, up to 4 
substitutions between cell- and plasma-derived sequence variants were considered as quasi-identical 
for the present study, likewise Chachage et al. (2016). In 2 subjects (H76, H533) deletions in the V-
loop were detected for both in a relatively similar region. Additionally, a frameshift was found for 



































Fig. 4 Phylogenetic tree including subjects of the study of Chachage et al. (2016) with CD25+/FoxP3+Helios+, 
CD25+/FoxP3+Helios-, CD25-/FoxP3-Helios+ and CD25-/FoxP3-Helios- sorted populations and the present study with 
CD4low/-, CD4+CD25+/FoxP3+, CD4+CXCR5+ and CD4+CXCR5- sorted populations and plasma (Plasma) at Follow 
up 12 and at onset of infection (Plasma T0, first seropositive follow-up). Phylogenetic distances between various 




The wide phylogenetic distribution of cell-derived sequences in regard to plasma-derived sequences 
for the investigated 9 subjects indicate various memory T cell-subsets rather than a distinct cell subset 
may contribute to plasma viremia as the data does not indicate a coherence of a predominant cell 
subset derived sequences clustering with plasma virus sequences. 
The phylogenetic tree including the results of the study of Chachage et al. (2016, Fig. 4) provides an 
overview of the nucleotide sequence distribution. Regarding the hypothesis to find evidence for a 
distinct cell subset contributing to plasma viremia, comparing the phylogenetic distribution from 
CD4low/--derived, Tfh-derived, Treg-derived and non-Treg-derived nucleotide sequences respectively 
to the plasma-derived sequences, no distinct correlation could be detected for a certain cell population 
contributing to plasma viral replication. 
 
3.6 HIV nucleotide variations between plasma- and cell-derived sequences 
 
The nucleotide distance of plasma to cell differed with a variation between approximately 0 up to 
25%, the mean values between approximately 1 to 8% and the interquartile ranges, the middle 50% 
between the upper and lower quartile, varied approximately between 1 to 12.5%. 
Significant increased nucleotide variation in correlation to the infection duration could not be detected 
with continuity as the distribution of nucleotide variation in subjects with shorter infection duration 
showed partially larger nucleotide variation (H442; 21-24 months infected; Fig. 5) in comparison to 
subjects with longer infection duration (H346; 24-27 months infected; Fig. 5). Further, for all 
subjects, infected over 36 months, varying nucleotide distribution with significant differences were 
detected (H457 with large nucleotide variation in comparison with H293, H446, H241 and H76; Fig. 
5). A distribution of 2 clusters with significant diverse distances from the plasma-derived nucleotide 
sequences was detected for H533 and earlier in the study of Chachage et al. (2016) for H8710. 
Although these findings may be explained by dual infection evidence for H533 (Table 1, Fig. 9), no 





































With the shortest infection time of 21-24 months a large cluster of 1 Tfh-cell-derived nucleotide 
population with 10 plasma-derived nucleotide sequences (H442; Q4; Fig. 3; Table 11) was detected 
but also for subjects infected over 36 months large populations of 17 CD25+/FoxP3+ cell-derived 
nucleotide sequences clustering with 2 plasma-derived sequences could be detected (H241; Q2; Fig. 
3; Table 11). 
 
Dual infection evidence may be an explanation for the discontinuity of nucleotide variation increase 
over time. Various subjects were previously found to be dual infected by the time of this study onset 
(H574, H605, H442, H533, 241; Table 1) while dual infection evidence was detected during the 
phylogenetic analysis during this study (H8975, 9440, H457, H346; Fig. 7; Fig. 8; Fig. 9). Hence, 
viral sequence variation seems to underline multiple variables, which may have an impact on the 




Fig. 5 Nucleotide distance variation (in %) of plasma-derived nucleotide sequences for the 9 subjects of this 
study and the 6 subjects of the study of Chachage et al. (2016). Each value represents a plasma-derived 
nucleotide sequence at its distance to a distinct cell-derived nucleotide sequence. The horizontal red bars 















































Table 12 Nucleotide variation maximum, Mean and Interquartile range for within plasma and plasma to the 
distinct cell population of interest for all 9 subjects (in %) 




maximum in % 
8 6 10 5 5 15 4 6 6 
Plasma 
Mean in % 4 3 3 1 3 5 2 3 3 
Plasma 
Interquartile 
range in % 




maximum in % 
9  10 14      
CD4 low/- 
Mean in % 5  4 8      
CD4 low/- 
Interquartile 
range in % 




maximum in % 
 6 10 13 6  4 7 6 
CD25+/FoxP3+ 
Mean in %  3 3 9 3  2 4 4 
CD25+/FoxP3+ 
Interquartile 
range in % 




maximum in % 
 7 10 13 8 21  7  
CXCR5+ 
Mean in %  4 3 7 3 9  5  
CXCR5+ 
Interquartile 
range in % 




maximum in % 
10 
 
10 14 6 19 12   
CXCR5- 
Mean in % 7  3 7 3 7 10   
CXCR5- 
Interquartile 
range in % 






















Respectively nucleotide variations within plasma and the individual cell populations to the plasma 
are presented for each subject (Fig. 6, Appendix: S2, S4, S6, S8, S10, S12, S14, S16). The nucleotide 
variation maximum, mean and interquartile range are presented for each subject (Table 12). 
Nucleotide distance maxima within plasma populations with approximately 15% variation, from 
CXCR5+populations to plasma with approximately 21% variation and from CXCR5- populations to 
plasma with approximately 19% variation were detected with the largest maxima for H457 (>36 
infected; Appendix: S10; Table 12).  
For the CD4low/- population with approximately 14% as well as for the CD25+/FoxP3+ population with 
approximately 13% largest nucleotide variation maxima were detected for H442 (21-24 months 
infected; Fig. 6; Table 12). For latter subject two considerably independent plasma subpopulations 
were detected, one with a minimal nucleotide variation maximum of approximately 1% and a second 
of an approximate 5% nucleotide variation maximum. These findings may be explained by dual 
infection. 
Considering the assumption that time of infection may be accompanied with nucleotide variation 
increase the findings of this study are controversy. Plasma nucleotide variation maxima were lowest 
for H533 (>36 months infected; Appendix: S12; Table 12) with approximately 4% and highest for 
H457 (>36 months infected; Appendix: S10; Table 12) with approximately 15%. Within the CD4low/- 
population lowest nucleotide variation maxima with approximately 9% were detected for H76 (>36 
Fig. 6 Nucleotide variation within plasma and for all plasma-derived sequences to each 




months infected; Appendix: S2; Table 12) and largest nucleotide variation maxima with 
approximately 14% were detected for H442 (21-24 months infected; Fig. 6; Table 12). Latter 
nucleotide variation discrepancy regarding the infection duration may be explained by dual infection 
evidence for H442. Similar discrepancy could be detected for the CD25+/FoxP3+ population were 
lowest nucleotide variation maximum of approximately 4% was found for H533 (>36 months 
infected; Appendix: S12; Table 12) and largest nucleotide variation maximum for H442 with 
approximately 13% (21-24 months infected; Fig. 6; Table 12). For the CXCR5+ populations lowest 
nucleotide variation maxima with approximately 7% were found for H293 (>36 months infected; 
Appendix: S4; Table 12) and H241 (>36 months infected; Appendix: S14; Table 12) and largest 
nucleotide variation maxima for H457 with approximately 21% (>36 months infected; Appendix: 
S10; Table 12). For the CXCR5- population lowest nucleotide variation maximum was found for 
H446 with approximately 6% (>36 months infected; Appendix: S8; Table 12) and largest nucleotide 
variation maximum for H457 with approximately 19% (>36 months infected; Appendix: S10; Table 
12).  
This controversy of nucleotide variation increase, not necessarily being accompanied with infection 
prolongation, may partially be explained by dual infection evidence (H442, H457, H533, H346 and 
H241) but additionally seem to underline the assumption, that multiple factors may be involved in 
nucleotide alterations. Hence, multiple cell populations rather than a single cell subset may contribute 




During analysis, processing phylogeny indicated coinfection for distinct subjects of this study, as 
their phylogenetic distance could not be explained by nucleotide variation over time but rather 
coinfection. 
Through further analysis within the viral sequence, evidence of dual infection was confirmed in the 
V1C2 region (HxB2 6615→7025) for H442 with a significant distance of 2 clusters of nucleotide 








































Within the V3 region (HxB2 7026→7245), evidence for dual infection was detected for 9440 and 
H457 with large distances of two phylogenetic populations for each subject. In the same region 
evidence for coinfection was again detected for H442 with two phylogenetic populations significantly 






Fig. 7 Phylogenetic analysis of the V1C2 region of HxB2: 6615→7025) for dual infection. For subject H442 































For the same region, within the genome sequence of 7008→7223, evidence for coinfection was 







Fig. 8 Dual infection evidence for subject 9440, H457 and H442 within the V3 region of HxB2: 































H442 and H533 had former been determined as dual infected by Multi-region Hybridization assay 
(MHA). Dual infection status for 9440 and 8975 remained unknown (Appendix: Table 13) until this 
study and for H457 and H346 single infection status had been determined by MHA before this 
phylogenetic analysis. These results demonstrate that all these subjects were infected with more than 
one HIV strain.
Fig. 9 Within the genome sequence of 7008→7223 coinfection for 8975, H346 and H533, latter previously known 





The extend of HIV disease progression is highly dependent on active HIV replication in CD4+ cells 
and therefore, predicted by the HIV plasma viral load (Mellors et al., 1996; Ioannidis et al., 1996). 
While HIV infection rates vary for different CD4 T cell populations (Brenchley et al., 2004a; 
Brenchley et al., 2004b; Chomont et al., 2009; Ganesan et al., 2010), memory CD4+ T cells seem to 
be the dominant substrate for virus replication throughout most of the infection duration (Veazey et 
al., 1998; Zhang et al., 1999; Haase, 1999; Schacker et al., 2001). It still remains unknown to what 
degree particular immune cell populations contribute to plasma virus production. 
 
To assess the possible contribution of distinct memory T cells to plasma virion production, blood 
samples of 9 subjects with ART-naive HIV-1 infection were included in this study in order to 
phylogenetically analyze and compare the highly variable EnvV1V3 region sequences of plasma 
virus with viral sequences derived from sorted memory (CD45RA-) T cell subpopulations. These 
included CD4low/-, Treg cells (CD4+CD25+/FoxP3+), Tfh cells (CD4+CXCR5+) and non-Tfh cells 
(CD4+CXCR5-). The infection duration at the time of blood sampling varied from 21-24 months 
(subject H442), 24-27 months (subject H346), 30-33 months (subject H304) and >36 months 
(subjects H76, H457, H533, H293, H446, H241). The EnvV1V3 region could be amplified in the 
CD4low/- memory T cell subsets for 3 subjects, in the CD4+CD25+/FoxP3+ cells for 7 subjects, in 
CD4+CXCR5+ and CD4+CXCR5- in 6 subjects. Subsequent cloning of the PCR products enabled 
genetic sequencing and later comparison of EnvV1V3 between cell-derived and plasma-derived 
populations.  
 
The EnvV1V3 amplicon sequence variation, introduced by nested PCR amplification was assessed 
with an endpoint-diluted positive control plasmid (Du422 clone 1), as previously described by 
Chachage et al. (2016). 80% of cloned amplicon EnvV1V3 sequences differed only by ≤2 nucleotide 
substitutions, without insertions or deletions. However, up to 4 substitutions were considered as 
quasi-identical between cell- and plasma-derived sequence variants, regarding the performed nested 
PCR with 2 rounds. 
 
Despite the relatively low number of sorted cells used for the nested EnvV1V3 PCR reaction, most 
amplicons were detected within the sorted CD25+/FoxP3+ CD4 T cells (7 out of the 9 subjects), 
followed by EnvV1V3 amplification in 6 out of the 9 subjects for CXCR5+ and CXCR5- CD4 T cells 
and only 3 subjects with EnvV1V3 amplification for the CD4low/-population (blue colored values, 
Table 10). These results are consistent with the results of Chachage et al. (2016) showing that HIV 
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DNA loads are comparatively high in the CD25+/FoxP3+ memory CD4 T cell population. However, 
within the Treg cell populations in the present study, out of the 7 EnvV1V3 amplicons only for 1 
subject a quasi-identical cluster of 17 Treg derived sequences and 2 plasma derived sequences were 
detected. Consequently, within this subject, Tregs may have been recently infected or were actively 
contributing to plasma virus at the time of blood sampling. These data argue against a major 
contribution of circulating Treg cells to plasma virion production in ART naive HIV positive subjects, 
despite their comparatively high infection rates (Chachage et al., 2016). 
 
As mentioned above in 6 out of 9 subjects EnvV1V3 amplicons were detected in the CXCR5+ T cell 
population, which is consistent with a high HIV infection rate of this cell subset, considering the 
relatively low numbers of sorted cells. However, similar to the Treg population, only 1 quasi-identical 
sequence cluster was found with 1 Tfh-derived EnvV1V3 sequence clustering with 1 plasma-derived 
sequence (H304; Q3, Fig. 3; Table 11). Lymph node Tfh cells are considered to be a major substrate 
for HIV viral replication as evident by the correlation of HIV DNA load in these cells and the plasma 
viral load (Perreau et al., 2013). Potential explanations for the disparities between the present study 
and the results from Perreau et al. (2013) include primarily the investigation of sorted circulating, but 
not LN derived Tfh cells in the present study. Further different phenotypic markers were used to 
define the Tfh subset. This study used solely CXCR5 to define Tfh cells, whereas Perreau et al. (2013) 
used T cells that co-expressed CXCR5 and PD1. Hence it is not completely clear whether CXCR5+ 
cells truly represent Tfh cells, as CXCR5+ memory T cells include both PD1 positive and PD1 
negative cell populations.  
 
In peripheral blood CXCR5- memory CD4 T cells represent the major memory CD4 T cell population. 
In 6 out of 9 subjects the EnvV1V3 region could be amplified. In 3 of these 6 subjects quasi-identical 
sequence clusters were detected within this non-Tfh, non-Treg memory cell population: H304 (1 non-
Tfh cell derived nucleotide sequence clustering with the previously mentioned quasi-identical pair of 
1 Tfh and 1 plasma derived nucleotide sequence; Q3, Fig. 3; Table 11), H442 (1 non-Tfh cell derived 
nucleotide sequence clustering with 10 plasma-derived sequences; Q4, Fig. 3; Table 11) and H446 (1 
non-Tfh cell derived nucleotide sequence clustering with 1 plasma-derived sequence; Q6, Fig. 3; 
Table 11 and another quasi-identical pair of 2 non-Tfh cell derived nucleotide sequences clustering 
with another plasma-derived sequence; Q7, Fig. 3; Table 11). Noticeably, for H304 the quasi-identical 
cluster of 1 Tfh (CXCR5+) and 1 non-Tfh (CXCR5-) population with 1 plasma-derived population 
can be interpreted that either both cell populations had recently become infected by the same (or 
highly similar) virus or that CXCR5 expression was up or downregulated in the offspring of a cell 
that had become HIV infected. Unfortunately, little is known about whether differentiated cells of a 
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specific lineage, such as Tregs or Tfh, can convert back into a less differentiated cell type. 
 
Only in 3 out of 9 subjects the EnvV1V3 region could be amplified in the CD4low/- memory T cell 
population. Interestingly, 2 of these 3 cell-derived sequences showed quasi-identical clusters with 
plasma virus sequences. For H76 1 cluster contained 3 cell-derived sequences clustering with 4 
plasma derived sequences (Q1, Fig. 3, Table 11) and for H442 1 cell-derived sequence clustered with 
1 plasma-derived sequence (Q5, Fig. 3, Table 11). This relative accumulation of quasi-identical 
clusters in the CD4low/- memory T cell subset could be the result from productive HIV infection and 
thus, HIV-1 induced downregulation of the CD4 surface expression as described earlier (Kaiser et 
al., 2007). Hence, our results are consistent with those reported by Kaiser et al. (2007), which showed 
that CD4low/- memory T cells contained the highest proportion of unspliced (us) HIV RNA per 106 
cells (Kaiser et. 2007) and therefore, play a crucial role in HIV plasma virion production.  
 
Quasi-identical sequence-clusters could be detected in 5 out of the 9 subjects, whereas generally 
within the EnvV1V3 amplicons, a large sequence variability was detected in all investigated subjects. 
These findings suggest that rather than a single T cell subset, more likely various memory T cell 
subsets support the viral replication cycle and are involved in ongoing plasma virus production. 
Furthermore, individual EnvV1V3 sequences derived from plasma and cellular compartments were 
often very highly variable and intermingled in the absence of compartmentalization. Hence, each of 
these individual sequences must have originated from a different cellular source, producing plasma 
virus (or became recently HIV infected) at any given time point. Blood accounts for an average of 
8% of the body weight. As we only analyzed a few milliliters of the average 5 to 8 liters of total 
human blood volume, these results highlight that a huge number of different cellular sources produce 
plasma virus simultaneously in viremic subjects. 
 
In consideration of the different times since infection, Chachage et al. (2016) detected a correlation 
of infection duration with increasing EnvV1V3 sequence variation and decreasing rates of quasi-
identical pairs between plasma and cell-associated sequences. The present study could not confirm 
these findings since no correlation of infection duration with decreasing frequencies of quasi-identical 
clusters between plasma and cell-derived EnvV1V3 sequences and thus increasing sequence variation 
was detected. A possible explanation could be that HIV infection had occurred more than once in 
some of our study subjects. Occurrence of unique recombinant forms between 2 or more different 
HIV strains could potentially mask the linear relationship between infection duration and increased 
viral diversity in an HIV positive subject off ART (McCutchan et al., 2005). In order to further 
investigate this assumption, all available EnvV1V3 sequences from 15 subjects, including those from 
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the Chachage et al. study (2016) were subjected to a detailed analysis of EnvV1V3 subregions. 
Indeed, various individuals must have been co-infected with different HIV strains, as evident by 
highly divergent variant sequences in the same EnvV1V3 subregion within the same individual. 
Evidence of such dual infection was detected, mainly in the V3 region at position HxB2 7026→7245 
(H442, H457, 9440) and at position 7008→7223 (H533, H346, 8975). Additionally, for H442 
evidence for dual infection was also confirmed in the V1C2 region at position HxB2 6615→7025. 
These results underline that dual HIV infections were quite common in female bar workers from the 
HISIS study, conducted from 2000-2005, but also in further subjects from a more recent study 
conducted in the Mbeya region, Tanzania (Worm-HIV infection, conducted from 2010-2013 (Arroyo 
et al., 2005; Chachage et al., 2014).  
 
Only 2 out of 7 co-infected individuals had quasi-identical cluster pairs between plasma and cell-
derived sequences. As dual infection may undergo "unique" possible interchange, specifically genetic 
recombination between viral strains with non-linearly increasing viral diversity, the detection of 
circulating viral species as quasi-identical clusters between plasma- and cell-derived sequences and 
therefore, EnvV1V3 sequences of distinct cell populations as predominant origins of plasma viremia 
may presumably be more unlikely to be detected. 
 
Considering the fact that EnvV1V3 nucleotide variation did not correlate directly with infection 
duration or dual infection status in this study, additional variables may also be important and likely 
include viral load, extend of natural immune control and intrinsic properties of infected cells, such as 
APOBEC activity, a family of cellular polynucleotide cytidine deaminases that are potent inhibitors 
of HIV-1 infection (Malim et al., 2009). Hence, the frequency of quasi-identical cell-plasma sequence 
pairs in an individual may be influenced by multiple factors. 
 
Earlier studies have used different approaches to identify potential cellular sources of the plasma 
virus. In the study of Kaiser et al. (2007) approximately 10000 copies of usRNA HIV nucleic acid 
copies/106 PBMCs were detected in activated CD4+ T cells, which are considered a major substrate 
for HIV replication (Maier et al., 2000). The highest levels of almost 15000 usRNA HIV nucleic acid 
copies/106 PBMCs were detected in CD4-/CD8- T cells, probably related to the HIV-1 induced 
downregulation of the CD4 surface expression, as an effect of productive HIV infection (Kaiser et 
al., 2007). The results of this study are consistent with the latter finding, as for the 3 subjects, in which 
EnvV1V3 was successfully amplified, quasi-identical clusters in 2 subjects could be detected between 
CD4low/-CD8- memory T cell-derived and plasma-derived sequences. 
A study of a nonhuman primate (NHP) SIV infection model used in situ HIV RNA hybridization to 
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identify transcriptionally active cellular SIV reservoirs in different organs, but excluding the blood 
compartment (Estes et al., 2017). This study showed that in the absence of ART more than 98% of 
detectable vRNA+ and vDNA+ cells can be found in LT, particularly in LN and GALT (Estes et al., 
2017). LT contains high numbers of Tfh and other memory CD4 T cells that should be susceptible to 
productive HIV infection (Perreau et al., 2013, Banga et al., 2016). The infected cell pool in blood 
contains archival, quiescent proviruses, within highly differentiated cells, which appeared clonally 
expanded and occasionally expressed virions upon stimulation (Boritz et al., 2016). Homeostatic 
cellular proliferation may indeed be an important mechanism contributing to persistence of HIV in 
vivo by passing on HIV proviral DNA without the production of virions (Chomont et al., 2009). High 
homeostatic proliferation of HIV infected Tregs could potentially contribute to the high frequency of 
detected EnvV1V3 amplicons without a high number of quasi-identical clusters with concurrent 
plasma-derived sequences.  
 
In this study, about 3,5x105 of memory T cells were sorted from a median of about 10x106 PBMCs. 
From this cell pool, a median of about 8 x104 cells and a median 1x104 were sorted for the CD4low/- 
memory T cell subset (median 23% of memory CD3+ cells) and CD25+/FoxP3+ cells (median of 2,9% 
CD4+ memory T cells), respectively. From the remaining memory CD4+ T cells, a median of 6x104 
and 2x105 were sorted for CXCR5+ (median 17%) and CXCR5- (median 57%) were sorted 
respectively. 
 
After FACS, during cell lysis, a minimum of 10mM TRIS-HCl buffer of 30 µl was layered above the 
sorted cell pellet. From this cell-buffer dilution only 10 µl was used in the first-round nested PCR. 
Hence, cellular DNA corresponding to only 1 third of the sorted cells was used for amplification in 
the EnvV1V3 nested PCR. A median of 10 µl of plasma and a median of 15 µl from the second-round 
PCR product was then used for DNA gel extraction after gel electrophoresis and only 2 µl of 50 µl 
eluted EnvV1V3 amplicons were finally used for molecular cloning. Hence, the number of sorted 
cells and plasma-associated HIV sequences, that were included in our phylogenetic analyses, only 
represent a very tiny fraction of the HIV sequences that exist in blood in vivo.     
 
Future studies may increase the validity of phylogenetic relationships between plasma- and certain 
cell subset-derived HIV sequences by studying much larger cell numbers and significantly larger rates 
of HIV sequences per cell subset and plasma. Furthermore, amplification of the target sequence 
within each cell population may increase sensitivity of EnvV1V3 PCR due to larger DNA quantities. 
Although investigations of the human LT may be challenging due to invasive procedures and thus 
ethical issues, analysis of these compartments with significantly higher levels of vRNA+ and vDNA+ 
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cells will be important to understand the cellular source of plasma virus production.  
 
In conclusion, the hypothesis of preferential plasma virion production from a specific memory T cell 
population could not be supported in this study. Moreover, the question arises whether once the 
reservoir of HIV-1 DNA infected cells is established, which parameters influence their lifespan and 
what influences their long-term reservoir contribution. Therefore, still little is known about the 
cellular source of active plasma virus production.  
 
Innovative phylogenetic correlations and insights into the compartmentalized intra-host population 
dynamics will provide new perspectives in understanding the persistence of HIV-1 in its host 
environment. These consolidated findings will facilitate meliorating of cellular pharmacokinetics and 
spatial distribution of ART to entirely inhibit viral replication and sustain immune system function 
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Subject Infecion status by the 
time of blood sample 
collection 
Subtype Dual infection evidence 
 H574            9-12 months                 AC                Dual 
 H605          27-30 months                 AC                Dual 
 6233K12          16-38 months                    C             unknown 
 9440A11a             >38 months                    C             unknown 
 8710U11             >38 months                    C             unknown 
 8975T11             >54 months                    C             unknown 
 















S1 Gating tree of subject H76 
S2 Nucleotide variation between plasma and cell-derived viral 
















S3 Gating tree for subject H293 
S4 Nucleotide variation between plasma and cell-derived viral 














S5 Gating tree for subject H304 
S6 Nucleotide variation between plasma and cell-derived viral 






S7 Gating tree for subject H446 
S8 Nucleotide variation between plasma and cell-derived viral 





S10 Nucleotide variation between plasma and cell-derived viral 
nucleotide sequences for subject H457 





S11 Gating tree for subject H533 
S12 Nucleotide variation between plasma and cell-derived viral 





S13 Gating tree for subject H241 
S14 Nucleotide variation between plasma and cell-derived viral  





S15 Gating tree for subject H346 
S16 Nucleotide variation between plasma and cell-derived viral 
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